Advertisement
Screener

DarioHealth Corp. (DRIO) Net Income (Loss) Available to Common Stockholders, Basic

2.8 / 5 stars · 68/120 Roast Me

DarioHealth Corp. Net Income (Loss) Available to Common Stockholders, Basic

DarioHealth Corp. (DRIO) reported Net Income (Loss) Available to Common Stockholders, Basic of -$16.34 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2023-08-10

  • DarioHealth Corp. net income (loss) available to common stockholders, basic for the quarter ending 2023-06-30 was -$16.34M.
  • DarioHealth Corp. net income (loss) available to common stockholders, basic for the quarter ending 2023-03-31 was -$12.43M.
  • DarioHealth Corp. net income (loss) available to common stockholders, basic for the quarter ending 2022-12-31 was -$13.62M.
  • DarioHealth Corp. net income (loss) available to common stockholders, basic for the quarter ending 2022-09-30 was -$15.07M.
  • DarioHealth Corp. net income (loss) available to common stockholders, basic for fiscal 2022 was -$59.96M.
  • DarioHealth Corp. net income (loss) available to common stockholders, basic for fiscal 2021 was -$67.52M.
  • DarioHealth Corp. net income (loss) available to common stockholders, basic for fiscal 2020 was -$33.10M.
  • DarioHealth Corp. net income (loss) available to common stockholders, basic for fiscal 2019 was -$20.89M.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 3 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 6 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 9 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 12 monthNet Income (Loss) Available to Common Stockholders, Basic 12 month as first filed
2023-06-30-$16.34M
10-Q · filed 2023-08-10
-$28.85M
10-Q · filed 2023-08-10
-$42.39M
derived: sum of 3 quarters · filed 2023-08-10
-$57.46M
derived: sum of 4 quarters · filed 2023-08-10
2023-03-31-$12.43M
10-Q · filed 2023-05-11
-$26.05M
derived: sum of 2 quarters · filed 2023-05-11
-$41.12M
derived: sum of 3 quarters · filed 2023-05-11
-$57.73M
derived: sum of 4 quarters · filed 2023-08-10
2022-12-31-$13.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
-$28.69M
derived: sum of 2 quarters · filed 2023-03-09
-$45.30M
derived: sum of 3 quarters · filed 2023-08-10
-$59.96M
10-K · filed 2023-03-09
2022-09-30-$15.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$31.68M
derived: sum of 2 quarters · filed 2023-08-10
-$46.34M
10-Q · filed 2022-11-14
-$65.35M
derived: sum of 4 quarters · filed 2023-08-10
2022-06-30-$16.61M
10-Q · filed 2023-08-10
-$31.27M
10-Q · filed 2023-08-10
-$50.28M
derived: sum of 3 quarters · filed 2023-08-10
-$73.21M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$14.51M
10-Q · filed 2023-05-11
-$16.37M
10-Q · filed 2022-05-12
-$33.67M
derived: sum of 2 quarters · filed 2023-05-11
-$56.60M
derived: sum of 3 quarters · filed 2023-05-11
-$74.86M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$19.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
-$42.10M
derived: sum of 2 quarters · filed 2023-03-09
-$60.35M
derived: sum of 3 quarters · filed 2023-03-09
-$67.52M
10-K · filed 2023-03-09
-$78.77M
10-K · filed 2022-03-22
2021-09-30-$22.93M
10-Q · filed 2021-11-15
-$41.19M
derived: sum of 2 quarters · filed 2021-11-15
-$48.36M
10-Q · filed 2022-11-14
-$56.70M
10-Q · filed 2021-11-15
-$66.36M
derived: sum of 4 quarters · filed 2022-05-12
2021-06-30-$18.25M
10-Q · filed 2021-08-16
-$28.61M
10-Q · filed 2022-08-15
-$33.76M
10-Q · filed 2021-08-16
-$43.43M
derived: sum of 3 quarters · filed 2022-05-12
-$50.91M
derived: sum of 4 quarters · filed 2022-05-12
2021-03-31-$15.51M
10-Q · filed 2022-05-12
-$25.17M
derived: sum of 2 quarters · filed 2022-05-12
-$32.65M
derived: sum of 3 quarters · filed 2022-05-12
-$37.45M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$9.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22
-$17.14M
derived: sum of 2 quarters · filed 2022-03-22
-$21.94M
derived: sum of 3 quarters · filed 2022-03-22
-$33.10M
10-K · filed 2022-03-22
2020-09-30-$7.48M
10-Q · filed 2021-11-15
-$12.27M
derived: sum of 2 quarters · filed 2021-11-15
-$23.44M
10-Q · filed 2021-11-15
-$30.77M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$4.79M
10-Q · filed 2021-08-16
-$15.96M
10-Q · filed 2021-08-16
-$23.29M
derived: sum of 3 quarters · filed 2021-08-16
-$26.09M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$11.17M
10-Q · filed 2021-05-17
-$18.50M
derived: sum of 2 quarters · filed 2021-05-17
-$21.30M
derived: sum of 3 quarters · filed 2021-05-17
-$26.68M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$7.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09
-$10.13M
derived: sum of 2 quarters · filed 2021-03-09
-$15.52M
derived: sum of 3 quarters · filed 2021-03-09
-$20.89M
10-K · filed 2021-03-09
2019-09-30-$2.81M
10-Q · filed 2020-11-12
-$8.19M
derived: sum of 2 quarters · filed 2020-11-12
-$13.56M
10-Q · filed 2020-11-12
-$18.55M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$5.38M
10-Q · filed 2020-08-12
-$10.76M
10-Q · filed 2020-08-12
-$15.74M
derived: sum of 3 quarters · filed 2020-08-12
-$19.80M
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31-$5.38M
10-Q · filed 2020-05-12
-$10.36M
derived: sum of 2 quarters · filed 2020-05-12
-$14.42M
derived: sum of 3 quarters · filed 2020-05-12
-$20.75M
derived: sum of 4 quarters · filed 2020-05-12
2018-12-31-$4.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17
-$9.05M
derived: sum of 2 quarters · filed 2020-03-17
-$15.38M
derived: sum of 3 quarters · filed 2020-03-17
-$18.30M
10-K · filed 2020-03-17
2018-09-30-$4.06M
10-Q · filed 2019-10-28
-$10.39M
derived: sum of 2 quarters · filed 2019-10-28
-$13.31M
10-Q · filed 2019-10-28
-$16.83M
derived: sum of 4 quarters · filed 2019-10-28
2018-06-30-$6.33M
10-Q · filed 2019-08-13
-$9.25M
10-Q · filed 2019-08-13
-$12.77M
derived: sum of 3 quarters · filed 2019-08-13
-$15.74M
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31-$2.92M
10-Q · filed 2019-05-13
-$6.44M
derived: sum of 2 quarters · filed 2019-05-13
-$9.41M
derived: sum of 3 quarters · filed 2019-05-13
-$13.50M
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31-$3.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
-$6.49M
derived: sum of 2 quarters · filed 2019-03-25
-$10.59M
derived: sum of 3 quarters · filed 2019-03-25
-$16.00M
10-K · filed 2019-03-25
2017-09-30-$2.97M
10-Q · filed 2018-11-13
-$2.98M
10-Q · filed 2017-11-14
-$7.07M
derived: sum of 2 quarters · filed 2018-11-13
-$12.48M
10-Q · filed 2018-11-13
-$3.82M
10-Q · filed 2017-11-14
-$16.34M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$4.09M
10-Q · filed 2018-08-09
-$9.51M
10-Q · filed 2018-08-09
-$850.00K
10-Q · filed 2017-08-14
-$13.37M
derived: sum of 3 quarters · filed 2018-08-09
-$14.24M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31-$5.41M
10-Q · filed 2018-05-15
$3.24M
10-Q · filed 2017-05-15
-$9.27M
derived: sum of 2 quarters · filed 2018-05-15
-$10.15M
derived: sum of 3 quarters · filed 2018-05-15
-$14.21M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$3.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19
-$4.74M
derived: sum of 2 quarters · filed 2018-03-19
-$8.79M
derived: sum of 3 quarters · filed 2018-03-19
-$11.61M
10-K · filed 2018-03-19
2016-09-30-$876.00K
10-Q · filed 2018-03-19
-$2.01M
10-Q · filed 2016-11-10
-$4.93M
derived: sum of 2 quarters · filed 2018-03-19
-$7.75M
10-Q · filed 2018-03-19
-$6.37M
10-Q · filed 2016-11-10
-$9.43M
derived: sum of 4 quarters · filed 2018-03-19
2016-06-30-$4.06M
10-Q · filed 2018-03-19
-$2.72M
10-Q · filed 2016-08-11
-$6.87M
10-Q · filed 2018-03-19
-$4.36M
10-Q · filed 2016-08-11
-$8.55M
derived: sum of 3 quarters · filed 2018-03-19
-$10.38M
derived: sum of 4 quarters · filed 2018-03-19
2016-03-31-$2.82M
10-Q · filed 2018-03-19
-$1.64M
10-Q · filed 2016-05-11
-$4.50M
derived: sum of 2 quarters · filed 2018-03-19
-$6.32M
derived: sum of 3 quarters · filed 2018-03-19
-$8.48M
derived: sum of 4 quarters · filed 2018-03-19
2015-12-31-$1.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22
-$3.50M
derived: sum of 2 quarters · filed 2017-03-22
-$5.66M
derived: sum of 3 quarters · filed 2017-03-22
-$7.30M
10-K · filed 2017-03-22
2015-09-30-$1.83M
10-Q · filed 2016-11-10
-$3.99M
derived: sum of 2 quarters · filed 2016-11-10
-$5.62M
10-Q · filed 2016-11-10
-$9.11M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30-$2.16M
10-Q · filed 2016-08-11
-$3.80M
10-Q · filed 2016-08-11
-$7.28M
derived: sum of 3 quarters · filed 2016-08-11
-$13.61M
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31-$1.64M
10-Q · filed 2016-05-11
-$5.12M
derived: sum of 2 quarters · filed 2016-05-11
-$11.46M
derived: sum of 3 quarters · filed 2016-05-11
-$14.71M
derived: sum of 4 quarters · filed 2016-05-11
2014-12-31-$3.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-08
-$9.82M
derived: sum of 2 quarters · filed 2016-02-08
-$13.07M
derived: sum of 3 quarters · filed 2016-02-08
-$16.05M
10-K · filed 2016-02-08
2014-09-30-$6.33M
10-Q · filed 2015-11-13
-$9.59M
derived: sum of 2 quarters · filed 2015-11-13
-$12.57M
10-Q · filed 2015-11-13
2014-06-30-$3.25M
10-Q · filed 2015-08-12
-$6.24M
10-Q · filed 2015-08-12
2013-12-31$54.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24
-$3.42M
derived: sum of 2 quarters · filed 2015-03-24
-$13.93M
10-K · filed 2015-03-24
2013-09-30-$3.47M
10-Q · filed 2014-11-14
-$13.98M
10-Q · filed 2014-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
CVRx, Inc. (CVRX)United States$0.067B-2.62
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
TELA Bio, Inc. (TELA)United States$0.057B-0.82
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B
Pulmonx Corp (LUNG)United States$0.082B-1.16
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02